1 of the Largest Corporate Splits in History Is Coming to Wall Street in 2028 -- It's a Stock Up 737% Since Its IPO NASDAQ · Markets 28m ago
FDA Rejects NovoCure’s Optune Mya for Lung Cancer Brain Metastases. Here's What It Means for Investors. NASDAQ · Markets 38m ago
Accenture vs. Intuit: Does Corporate Consulting or Financial Software Make For a Better Stock Buy in 2026? NASDAQ · Markets 38m ago